secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pharma-Bio Serv, Inc. (PBSV)
CIK:        0001304161
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0001654954-24-007798
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pharma-Bio Serv Q2 revenue down 48% to $2.4M; net loss $0.2M vs income $0.4M
----------------------------------------------------------------------------

- Q2 revenue $2.4M, decline of $2.2M from $4.6M in prior-year quarter.
- Net loss $0.2M for the quarter; prior-year period net income was $0.4M.
- Six-month revenue $4.8M, down $4.0M; net loss of $0.5M vs income $0.8M.
- Management attributing decline to planned FY2024 investments in new client relationships and global events.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1304161/000165495424007798/0001654954-24-007798-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1304161/000165495424007798/pbsv_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-007798

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer